XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
EQUITY AWARDS (Tables)
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity

A summary of stock option activity in the Plan during the nine months ended September 30, 2022 and 2021 follows:

Nine Months Ended September 30, 2022

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

502,780

 

 

$

25.77

 

 

 

5.59

 

 

$

5,936

 

Granted

 

 

69,000

 

 

 

35.71

 

 

 

 

 

 

 

Exercised

 

 

(43,280

)

 

 

22.56

 

 

 

 

 

 

 

Forfeited

 

 

(29,920

)

 

 

27.21

 

 

 

 

 

 

 

Balance, September 30, 2022

 

 

498,580

 

 

$

27.34

 

 

 

5.62

 

 

$

3,725

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

283,910

 

 

$

24.96

 

 

 

4.20

 

 

$

2,733

 

 

Nine Months Ended September 30, 2021

 

Number of
Shares

 

 

Weighted-
Average
Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual
Life in
Years

 

 

Aggregate
Intrinsic
Value

 

Outstanding at beginning of year

 

 

506,200

 

 

$

26.81

 

 

 

5.82

 

 

$

1,805

 

Effect of 10% stock dividend

 

 

50,770

 

 

 

 

 

 

 

 

 

 

Granted

 

 

45,500

 

 

 

33.49

 

 

 

 

 

 

 

Exercised

 

 

(48,630

)

 

 

22.89

 

 

 

 

 

 

 

Forfeited

 

 

(19,020

)

 

 

26.01

 

 

 

 

 

 

 

Balance, September 30, 2021

 

 

534,820

 

 

$

25.22

 

 

 

5.53

 

 

$

5,684

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable at end of period

 

 

307,786

 

 

$

23.78

 

 

 

4.33

 

 

$

3,715

 

Schedule of Nonvested Stock Option Activity

A summary of nonvested stock option activity in the Plan during the nine months ended September 30, 2022 and 2021 follows:

Nine Months Ended September 30, 2022

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

207,084

 

 

$

5.23

 

Granted

 

 

69,000

 

 

 

6.56

 

Vested

 

 

(46,014

)

 

 

(5.90

)

Forfeited

 

 

(15,400

)

 

 

(9.09

)

Balance, September 30, 2022

 

 

214,670

 

 

$

5.53

 

 

Nine Months Ended September 30, 2021

 

Number of
Shares

 

 

Weighted-Average
Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

214,680

 

 

$

4.46

 

Effect of 10% stock dividend

 

 

23,218

 

 

 

 

Granted

 

 

45,500

 

 

 

5.82

 

Vested

 

 

(47,344

)

 

 

(5.72

)

Forfeited

 

 

(9,020

)

 

 

(8.06

)

Balance, September 30, 2021

 

 

227,034

 

 

$

5.11

 

Plan Information

Information related to stock options in the Plan is as follows for the nine months ended:

 

 

September 30, 2022

 

 

September 30, 2021

 

Intrinsic value of options exercised

 

$

521

 

 

$

630

 

Cash received from options exercised

 

 

976

 

 

 

1,113

 

Weighted average fair value of options granted

 

 

6.56

 

 

 

5.82

 

 

Summary of Restricted Stock Awards and Units Activity

A summary of restricted stock activity in the Plan during the nine months ended September 30, 2022 and 2021 follows:

Nine Months Ended September 30, 2022

 

Number of
Shares

 

 

Weighted-Average
 Grant
Date Fair Value

 

Outstanding at beginning of year

 

 

30,190

 

 

$

27.52

 

Vested

 

 

(4,770

)

 

 

(28.32

)

Balance, September 30, 2022

 

 

25,420

 

 

$

27.37

 

 

Nine Months Ended September 30, 2021

 

Number of
Shares

 

 

Weighted-Average
Grant
 Date Fair Value

 

Outstanding at beginning of year

 

 

35,300

 

 

$

29.72

 

Effect of 10% stock dividend

 

 

3,530

 

 

 

 

Granted

 

 

3,500

 

 

 

33.09

 

Vested

 

 

(7,850

)

 

 

27.26

 

Forfeited

 

 

 

 

 

 

Balance, September 30, 2021

 

 

34,480

 

 

$

27.41